Skip to content

Faculty profile

Michael Schlossmacher

Back to faculty
Full ProfessorCellular and Molecular MedicineUniversity of Ottawa

Latest papers

  • Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

    NPJ Parkinson's disease · 2021

  • Microglia depletion prior to lipopolysaccharide and paraquat treatment differentially modulates behavioral and neuronal outcomes in wild type and G2019S LRRK2 knock-in mice.

    Brain, behavior, & immunity - health · 2020

  • Canadian guideline for Parkinson disease.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019

All 5 publications

Latest funding

  • Oxidation of Parkin is Linked to Neuroprotection in Adult Mammalian Brain

    CIHR · 2020 · Nominated PI

    $879,750
  • Examining the role of LRRK2 in peripheral immune modulation of brain health

    CIHR · 2019 · Supervisor

    $105,000
  • Assessing the site and mechanism of Parkinson's disease initiation in vivo

    CIHR · 2016 · Co-investigator

    $761,175
All 12 grants and awards

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction